Sort
17,828 grants matching “crispr”
Project 3: A New Therapeutic Target for TERT Promoter Mutant Glioma
$363,524Joseph F Costello · University Of California, San Francisco · P50 · FY2020 · CA
Core B: Data Management and Bioinformatics Core
$363,451Orr Ashenberg · Harvard Medical School · U19 · FY2020 · AI
Core B: Data Management and Bioinformatics Core
$363,451Aviv Regev · Harvard Medical School · U19 · FY2019 · AI
Overcoming chemoresistance in triple negative breast cancer
$363,419Ozgur Sahin · Medical University Of South Carolina · R01 · FY2023 · CA
Morphogenesis and function of somatosensory axon ensheathment by epidermal cells
$363,399Alvaro Sagasti · University Of California Los Angeles · R01 · FY2022 · AR
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
$363,375John S Chorba · University Of California, San Francisco · R01 · FY2021 · HL
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
$363,375John S Chorba · University Of California, San Francisco · R01 · FY2022 · HL
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
$363,375John S Chorba · University Of California, San Francisco · R01 · FY2024 · HL
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
$363,375John S Chorba · University Of California, San Francisco · R01 · FY2023 · HL
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$363,351James A Wells · University Of California, San Francisco · R01 · FY2021 · CA
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models
$363,340Hariharan Easwaran · Johns Hopkins University · R01 · FY2019 · CA
Identifying the pathways that drive progression of the MPNs to AML
$363,268John D Crispino · Northwestern University At Chicago · R01 · FY2020 · CA
Peripheral Receptor Mechanisms in Orofacial Muscle Pain
$363,268Jin Y Ro · University Of Maryland Baltimore · R01 · FY2022 · DE
Nucleolar Genomics During Early Mammalian Development
$363,257Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · U01 · FY2019 · DA
Mechanistic Studies of the Type I CRISPR-Cas System
$363,204Scott Bailey · Johns Hopkins University · R01 · FY2017 · GM
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
$363,125Harold H Koeffler · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
$363,125Harold H Koeffler · Cedars-Sinai Medical Center · R01 · FY2018 · CA
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
$363,125Harold H Koeffler · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
$363,125Harold H Koeffler · Cedars-Sinai Medical Center · R01 · FY2016 · CA
Mechanisms of epigenetic memory in human cells
$363,057James Karlo Nunez · University Of California Berkeley · R35 · FY2024 · GM
In vivo motif selectivity and functionality of TALE family TFs
$363,037Charles G Sagerstrom · University Of Colorado Denver · R01 · FY2021 · GM
RNA targeting tools with novel specific RNA-guided RNA-targeting CRISPR effectors
$363,027Jonathan Samuel Gootenberg · Massachusetts Institute Of Technology · R56 · FY2021 · HG
Epigenetic Regulation of Osteoclastogenic Gene Expression: Factors, Targets, and Mechanisms
$363,000Woojin An · University Of Southern California · R01 · FY2019 · AR
Epigenetic Regulation of Osteoclastogenic Gene Expression: Factors, Targets, and Mechanisms
$363,000Woojin An · University Of Southern California · R01 · FY2023 · AR
Epigenetic Regulation of Osteoclastogenic Gene Expression: Factors, Targets, and Mechanisms
$363,000Woojin An · University Of Southern California · R01 · FY2020 · AR